And so, and, you know, if you fast forward another six months to this patient, because now we've had her in the practice for a year and a half, fast forward another six months, she , she's doing so well
Semaglutide Informed Consent Pg 3
Sedentary lifestyle: overview of updated evidence of potential health risks
The missing glucagon component means tirzepatide-based stacks lack the thermogenic and lipolytic advantages that glucagon agonism provides
Patients achieved substantial weight loss during the initial GLP-1 RA phase (~1822% at 12 months), which was subsequently maintained after its discontinuation, with total weight reduction reaching 25.5% (95% CI 23.127.9%) at 593 days, with most patients on metformin
Understanding these aspects of UMR coverage is essential when considering weight loss medications